Multiparameter Optimization of Naphthyridine Derivatives as Selective alpha 5-GABA(A) Receptor Negative Allosteric Modulators

摘要

The discovery and characterization of novel naphthyridine derivatives with selective alpha 5-GABA(A)R negative allosteric modulator (NAM) activity are disclosed. Utilizing a scaffold-hopping strategy, fused 6 + 6 bicyclic scaffolds were designed and synthesized. Among these, 1,6-naphthyridinones were identified as potent and selective alpha 5-GABA(A)R NAMs with metabolic stability, cardiac safety, and beneficial intellectual property (IP) issues. Relocation of the oxo acceptor function and subsequent modulation of the physicochemical properties resulted in novel 1,6-naphthyridines with improved profile, combining good potency, selectivity, ADME, and safety properties. Besides this, compound 20, having the most balanced profile, provided in vivo proof of concept (POC) for the new scaffold in two animal models of cognitive impairment associated with schizophrenia (CIAS).